Success Metrics

Active Trials
2(22%)

Phase Distribution

Ph phase_3
1
11%
Ph phase_2
2
22%
Ph phase_1
5
56%
Ph early_phase_1
1
11%

Phase Distribution

6

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
5(55.6%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
1(11.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Other(3)

Detailed Status

Not yet recruiting4
unknown3
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (11.1%)
Phase 15 (55.6%)
Phase 22 (22.2%)
Phase 31 (11.1%)

Trials by Status

active_not_recruiting111%
not_yet_recruiting444%
recruiting111%
unknown333%

Recent Activity

2 active trials
Showing 5 of 9
not_yet_recruitingphase_2

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

NCT03378414
not_yet_recruitingphase_1

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

NCT07131540
not_yet_recruitingphase_3

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial

NCT07075315
not_yet_recruitingphase_1

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

NCT06505941
recruitingphase_1

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

NCT06492798
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT03378414Phase 2

Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia

Not Yet Recruiting
NCT07131540Phase 1

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF)

Not Yet Recruiting
NCT07075315Phase 3

National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial

Not Yet Recruiting
NCT06505941Phase 1

Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS

Not Yet Recruiting
NCT06492798Phase 1

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

Recruiting
NCT06448052Phase 1

Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation

Active Not Recruiting
NCT03800810Early Phase 1

Implantation of Allogenic Mesenchymal Stem Cell From Umbilical Cord Blood for Osteoarthritis Management

Unknown
NCT02763423Phase 2

Allogeneic Umbilical Cord Mesenchymal Stem Cell Transplantation for Type 1 Diabetes With Diabetic Ketoacidosis

Unknown
NCT02285673Phase 1

Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy

Unknown

All 9 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9